Acute Vascular Events: Cellular and Molecular Mechanisms

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. An estimated 17.9 million individuals died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Cardiometabolic risks, such as hypertension, excess weight, obesity,...

Full description

Bibliographic Details
Main Authors: Varun HK Rao, Rasika T Shankar, Gundu H. R. Rao
Format: Article
Language:English
Published: International Medical Research and Development Corporation 2023-09-01
Series:International Journal of Biomedicine
Subjects:
Online Access:http://www.ijbm.org/articles/i51/ijbm_13(3)_ra1.pdf
_version_ 1797690932528676864
author Varun HK Rao
Rasika T Shankar
Gundu H. R. Rao
author_facet Varun HK Rao
Rasika T Shankar
Gundu H. R. Rao
author_sort Varun HK Rao
collection DOAJ
description Cardiovascular diseases (CVDs) are the leading cause of death worldwide. An estimated 17.9 million individuals died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Cardiometabolic risks, such as hypertension, excess weight, obesity, type 2 diabetes, and vascular diseases, contribute significantly to the progression of coronary artery disease. Known sequelae of events that lead to these cardiometabolic diseases include oxidative stress, inflammation, development of dysfunction of vascular adipose tissue, altered blood pressure and blood lipids, altered glucose metabolism, hardening of the arteries, endothelial dysfunction, development of atherosclerotic plaques, and activation of platelet and coagulation pathways. The Framingham Heart Study Group has developed a Risk Score that estimates the risk of developing heart disease in a 10-year period. This group of experts has developed mathematical functions for predicting clinical coronary disease events. These prediction capabilities are derived by assigning weights to major CVD risk factors such as sex, age, blood pressure, total cholesterol, low-density lipoprotein, high-density lipoprotein cholesterol, smoking behavior, and diabetes status. Currently, there is a growing interest in the use of artificial intelligence and machine learning applications. AI-based mimetic pattern-based algorithms seem to be better than the conventional Framingham Risk Score, in predicting clinical events related to CVDs. However, there are limitations to these applications as they do not have access to data on the specific factors that trigger acute vascular events, such as heart attack and stroke. This overview briefly discusses some salient cellular and molecular mechanisms involved in precipitating thrombotic conditions. Further improvements in emerging technologies will provide greater opportunities for patient selection and treatment options. Several clinical studies have demonstrated that most CVDs can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical activity, and harmful use of alcohol. Early detection and better management of the modifiable risks seem to be the only way to reduce, reverse, or prevent these diseases.
first_indexed 2024-03-12T02:07:15Z
format Article
id doaj.art-78e73f14f6774294b7b6a5b21d752e7a
institution Directory Open Access Journal
issn 2158-0510
2158-0529
language English
last_indexed 2024-03-12T02:07:15Z
publishDate 2023-09-01
publisher International Medical Research and Development Corporation
record_format Article
series International Journal of Biomedicine
spelling doaj.art-78e73f14f6774294b7b6a5b21d752e7a2023-09-07T04:39:13ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292023-09-0113391610.21103/Article13(3)_RA1Acute Vascular Events: Cellular and Molecular MechanismsVarun HK Rao0Rasika T Shankar1Gundu H. R. Rao2South Asian Society on Atherosclerosis and Thrombosis, IndiaSouth Asian Society on Atherosclerosis and Thrombosis, IndiaLillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota, USACardiovascular diseases (CVDs) are the leading cause of death worldwide. An estimated 17.9 million individuals died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Cardiometabolic risks, such as hypertension, excess weight, obesity, type 2 diabetes, and vascular diseases, contribute significantly to the progression of coronary artery disease. Known sequelae of events that lead to these cardiometabolic diseases include oxidative stress, inflammation, development of dysfunction of vascular adipose tissue, altered blood pressure and blood lipids, altered glucose metabolism, hardening of the arteries, endothelial dysfunction, development of atherosclerotic plaques, and activation of platelet and coagulation pathways. The Framingham Heart Study Group has developed a Risk Score that estimates the risk of developing heart disease in a 10-year period. This group of experts has developed mathematical functions for predicting clinical coronary disease events. These prediction capabilities are derived by assigning weights to major CVD risk factors such as sex, age, blood pressure, total cholesterol, low-density lipoprotein, high-density lipoprotein cholesterol, smoking behavior, and diabetes status. Currently, there is a growing interest in the use of artificial intelligence and machine learning applications. AI-based mimetic pattern-based algorithms seem to be better than the conventional Framingham Risk Score, in predicting clinical events related to CVDs. However, there are limitations to these applications as they do not have access to data on the specific factors that trigger acute vascular events, such as heart attack and stroke. This overview briefly discusses some salient cellular and molecular mechanisms involved in precipitating thrombotic conditions. Further improvements in emerging technologies will provide greater opportunities for patient selection and treatment options. Several clinical studies have demonstrated that most CVDs can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical activity, and harmful use of alcohol. Early detection and better management of the modifiable risks seem to be the only way to reduce, reverse, or prevent these diseases.http://www.ijbm.org/articles/i51/ijbm_13(3)_ra1.pdfcardiovascular diseaseartificial intelligencethrombosisrisk factors
spellingShingle Varun HK Rao
Rasika T Shankar
Gundu H. R. Rao
Acute Vascular Events: Cellular and Molecular Mechanisms
International Journal of Biomedicine
cardiovascular disease
artificial intelligence
thrombosis
risk factors
title Acute Vascular Events: Cellular and Molecular Mechanisms
title_full Acute Vascular Events: Cellular and Molecular Mechanisms
title_fullStr Acute Vascular Events: Cellular and Molecular Mechanisms
title_full_unstemmed Acute Vascular Events: Cellular and Molecular Mechanisms
title_short Acute Vascular Events: Cellular and Molecular Mechanisms
title_sort acute vascular events cellular and molecular mechanisms
topic cardiovascular disease
artificial intelligence
thrombosis
risk factors
url http://www.ijbm.org/articles/i51/ijbm_13(3)_ra1.pdf
work_keys_str_mv AT varunhkrao acutevasculareventscellularandmolecularmechanisms
AT rasikatshankar acutevasculareventscellularandmolecularmechanisms
AT gunduhrrao acutevasculareventscellularandmolecularmechanisms